<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="cfb9309f-e0df-4a55-9542-0e869fce05fb"><labelDrug name="Micardis"><Normalization><mmtx cui="C0721704" preferredWord="Micardis" semType="phsu, orch"/></Normalization></labelDrug><generic name="telmisartan"/><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1" text="Drug Label for drug brand Micardis, containing telmisartan." type="negative"><entity charOffset="0:19" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Micardis," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="47:58" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.1" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="telmisartan." preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="26:34" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.2" text="micardis" type="Biomedical_Entity"><Normalization><mmtx cui="C0721704" phraseText="Drug Label for drug brand Micardis," preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.2"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.1.e.1"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.10" text="MICARDIS is contraindicated in patients with known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan or any other component of this product see Adverse Reactions (6.2)." type="negative"><entity charOffset="105:116" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.10.e.0" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="to telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.10.e.1" text="micardis" type="Biomedical_Entity"><Normalization><mmtx cui="C0721704" phraseText="MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.10.e.1" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.10.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11" lineNumber="30" text="Do not co-administer aliskiren with MICARDIS in patients with diabetes see Drug Interactions (7)." type="regular"><entity charOffset="0:20" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with MICARDIS" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:44" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.3" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="aliskiren with MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="62:70" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.0"><relations><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.4" ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.11.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13" lineNumber="35" text="&lt;item&gt;Do not co-administer aliskiren with MICARDIS in patients with diabetes (4)" type="regular"><entity charOffset="6:26" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="27:36" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with MICARDIS" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="42:50" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.3" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="aliskiren with MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="68:76" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.4" ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.13.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19" lineNumber="51" text="&lt;item&gt;Avoid concomitant use of an ACE inhibitor and angiotensin receptor blocker (5.6)" type="regular"><entity charOffset="34:47" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.0" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant use of an ACE inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="52:80" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.1" text="angiotensin receptor blocker" type="Drug_Class"><Normalization><mmtx cui="C0003018" phraseText="angiotensin receptor blocker" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="6:11" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.2" text="Avoid" type="Caution_Interaction"/><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.2"><relations><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.1" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.19.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27" text="In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of therapy with MICARDIS. " type="negative"><entity charOffset="36:47" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="with an activated renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="223:231" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.1" text="micardis" type="Biomedical_Entity"><Normalization><mmtx cui="C0721704" phraseText="with MICARDIS." preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="144:153" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="treated with high doses of diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.2"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.27.e.1"/></sentence><sentence biomedicalEntities="5" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32" lineNumber="68" text="Hyperkalemia may occur in patients on ARBs, particularly in patients with advanced renal impairment, heart failure, on renal replacement therapy, or on potassium supplements, potassium-sparing diuretics, potassium-containing salt substitutes or other drugs that increase potassium levels. " type="regular"><entity charOffset="0:12" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.0" text="Hyperkalemia" type="Specific_Interaction"/><entity charOffset="38:42" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.2" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="152:173" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.3" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="or on potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="175:202" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.4" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="204:241" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.5" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="251:287" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.6" text="drugs that increase potassium levels" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0597277" phraseText="potassium levels." preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C2946261" phraseText="potassium levels." preferredWord="Level" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.5" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.4" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.6" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.4" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.5"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.6"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.5"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.4" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.6"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.4"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.32.e.6"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.33" text="Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk." type="negative"><entity charOffset="42:54" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.33.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="periodic determinations of serum electrolytes to" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="74:85" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.33.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="possible electrolyte imbalances," preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.33.e.0" e2=""/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.38" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, anticipate changes in renal function in susceptible individuals. " type="negative"><entity charOffset="53:64" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.38.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.38.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.38.e.1" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.38.e.0"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39" text="In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure or renal dysfunction), treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. " type="negative"><entity charOffset="195:241" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.0" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin-converting enzyme (ACE) inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="246:278" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.1" text="angiotensin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0815017" phraseText="angiotensin receptor antagonists" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="73:84" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.3" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.39.e.3"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.41" text="In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen were observed. " type="negative"><entity charOffset="14:28" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.41.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="132:136" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.41.e.1" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="blood urea nitrogen" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.41.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.41.e.1"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.42" text="There has been no long term use of MICARDIS in patients with unilateral or bilateral renal artery stenosis, but anticipate an effect similar to that seen with ACE inhibitors." type="negative"><entity charOffset="35:43" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.42.e.0" text="micardis" type="Biomedical_Entity"><Normalization><mmtx cui="C0721704" phraseText="no long term use of MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="159:173" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.42.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="seen with ACE inhibitors." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.42.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.42.e.1"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43" text="5.6 Dual Blockade of the Renin-Angiotensin-Aldosterone System" type="negative"><entity charOffset="31:42" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="5.6 Dual Blockade of the Renin-Angiotensin-Aldosterone System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="43:54" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="5.6 Dual Blockade of the Renin-Angiotensin-Aldosterone System" preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="9:17" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.2" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="5.6 Dual Blockade of the Renin-Angiotensin-Aldosterone System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.43.e.1"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.44" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function (including acute renal failure) have been reported. " type="negative"><entity charOffset="41:52" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.44.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="53:64" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.44.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.44.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.44.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45" lineNumber="81" text="Dual blockade of the renin-angiotensin-aldosterone system (e.g., by adding an ACE-inhibitor to an angiotensin II receptor antagonist) should include close monitoring of renal function." type="regular"><entity charOffset="155:165" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.0" text="monitoring" type="Caution_Interaction"/><entity charOffset="78:91" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.2" text="ACE-inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="an ACE-inhibitor to an angiotensin II receptor antagonist" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="836"/></Normalization></entity><entity charOffset="98:132" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.3" text="angiotensin II receptor antagonist" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="an ACE-inhibitor to an angiotensin II receptor antagonist" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.0"><relations><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.45.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.46" text="The ONTARGET trial enrolled 25,620 patients 55 years old with atherosclerotic disease or diabetes with end-organ damage, randomizing them to telmisartan only, ramipril only, or the combination, and followed them for a median of 56 months. " type="negative"><entity charOffset="141:152" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.46.e.0" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="them to telmisartan only," preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="159:167" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.46.e.1" text="ramipril" type="Biomedical_Entity"><Normalization><mmtx cui="C0072973" phraseText="ramipril only," preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.46.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.46.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47" lineNumber="82" text="Patients receiving the combination of MICARDIS and ramipril did not obtain any additional benefit compared to monotherapy, but experienced an increased incidence of renal dysfunction (e.g., acute renal failure) compared with groups receiving telmisartan alone or ramipril alone. " type="regular"><entity charOffset="165:182" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.0" text="renal dysfunction" type="Specific_Interaction"/><entity charOffset="190:209" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.2" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="38:46" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.4" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="the combination of MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="51:59" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.5" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="ramipril" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.ddi.2"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.4" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.5" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.47.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48" lineNumber="82" text="Concomitant use of MICARDIS and ramipril is not recommended." type="regular"><entity charOffset="44:59" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.0" text="not recommended" type="Caution_Interaction"/><entity charOffset="19:27" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.2" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="Concomitant use of MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="32:40" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.3" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="ramipril" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.48.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50" lineNumber="87" text="Aliskiren: Do not co-administer aliskiren with MICARDIS in patients with diabetes. " type="regular"><entity charOffset="32:41" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with MICARDIS" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="11:31" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.1" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="47:55" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.3" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="aliskiren with MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="73:81" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.4" ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.50.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51" lineNumber="87" text="Avoid use of aliskiren with MICARDIS in patients with renal impairment (GFR 60 mL/min)." type="regular"><entity charOffset="0:5" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:36" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.3" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="with MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="54:70" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.0"><relations><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.4" ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.51.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52" lineNumber="88" text="Digoxin : When MICARDIS was co-administered with digoxin, median increases in digoxin peak plasma concentration (49%) and in trough concentration (20%) were observed. " type="regular"><entity charOffset="58:77|86:111" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.0" text="median increases in peak plasma concentration" type="Increase_Interaction"/><entity charOffset="58:74|122:145" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.2" text="median increases in trough concentration" type="Increase_Interaction"/><entity charOffset="78:85" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.4" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="median increases in digoxin peak plasma concentration" preferredWord="Digoxin" semType="strd, phsu, carb"/><mmtx cui="C0012265" phraseText="median increases in digoxin peak plasma concentration" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="15:23" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.5" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.ddi.2"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.4" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.52.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53" lineNumber="88" text="Therefore, monitor digoxin levels when initiating, adjusting, and discontinuing telmisartan for the purpose of keeping the digoxin level within the therapeutic range." type="regular"><entity charOffset="11:18" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="19:26" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="monitor digoxin levels" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="80:91" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.3" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="discontinuing telmisartan for the purpose of keeping" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.53.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54" lineNumber="89" text="Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists including MICARDIS. " type="regular"><entity charOffset="145:180" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.0" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="191:199" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.1" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="MICARDIS." preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="21:39|48:62" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.3" text="increases in serum concentrations" type="Increase_Interaction"/><entity charOffset="40:47" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.5" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="Reversible increases in serum lithium concentrations" preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="67:75" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.6" text="toxicity" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.1" drugClass="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.0"/><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.ddi.2"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.0" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.3" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.55" lineNumber="89" text="Therefore, monitor serum lithium levels during concomitant use." type="irregular"><entity charOffset="11:18" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.55.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="25:32" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.55.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="monitor serum lithium levels during concomitant use." preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.55.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.55.e.0"><relations><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.55.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54" text="Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists including MICARDIS. "><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.54.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56" lineNumber="90" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including telmisartan, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="127:134" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.0" text="elderly" type="SPAN"/><entity charOffset="136:151" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="199:225" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.2" text="compromised renal function" type="SPAN"/><entity charOffset="248:254" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="266:292" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="299:334" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.6" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="346:357" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.7" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan," preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="373:404" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.9" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="425:444" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.11" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.4"/><drugClassMembership drug="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.7" drugClass="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.6"/><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.9"><relations><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.ddi.2"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.11"><relations><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.2, Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.0, Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.1" ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.6" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.56.e.9" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58" lineNumber="90" text="Monitor renal function periodically in patients receiving telmisartan and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:69" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.2" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="74:87" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.3" text="NSAID therapy" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.58.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59" lineNumber="91" text="The antihypertensive effect of angiotensin II receptor antagonists, including telmisartan may be attenuated by NSAIDs including selective COX-2 inhibitors." type="regular"><entity charOffset="31:66" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.0" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.1" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="111:117" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="128:153" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.4" text="selective COX-2 inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="4:27|97:107" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.6" text="antihypertensive effect attenuated" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.1" drugClass="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.0"/><classClassMembership drugClass="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.4"/><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.3" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.59.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60" lineNumber="92" text="Ramipril and Ramiprilat : Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state Cmax and AUC of ramipril 2.3- and 2.1-fold, respectively, and Cmax and AUC of ramiprilat 2.4- and 1.5-fold, respectively. " type="regular"><entity charOffset="126:153" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.0" text="increases steady-state Cmax" type="Increase_Interaction"/><entity charOffset="126:148|158:161" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.2" text="increases steady-state AUC" type="Increase_Interaction"/><entity charOffset="126:148|211:215" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.4" text="increases steady-state Cmax" type="Increase_Interaction"/><entity charOffset="126:148|220:223" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.6" text="increases steady-state AUC" type="Increase_Interaction"/><entity charOffset="47:58" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.8" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0990503" phraseText="Co-administration of telmisartan 80 mg" preferredWord="telmisartan 80 MG" semType="clnd"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="165:173" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.9" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="AUC of ramipril 2.3-" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="227:237" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.10" text="ramiprilat" type="Drug"><Normalization><mmtx cui="C0072970" phraseText="AUC of ramiprilat 2.4-" preferredWord="ramiprilat" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="80:88" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.11" text="ramipril" type="Drug"><Normalization><mmtx cui="C0989604" phraseText="ramipril 10 mg" preferredWord="Ramipril 10 MG" semType="clnd"/><RxNorm RxCui="35296"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.9"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.ddi.2"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.9"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.ddi.3"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.4"><relations><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.ddi.4"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.6"><relations><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.8"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.8" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.9" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.8" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.10" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61" lineNumber="92" text="In contrast, Cmax and AUC of telmisartan decrease by 31% and 16%, respectively. " type="irregular"><entity charOffset="13:17|41:49" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.e.0" text="Cmax decrease" type="Decrease_Interaction"/><entity charOffset="22:25|41:49" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.e.2" text="AUC decrease" type="Decrease_Interaction"/><entity charOffset="29:40" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.e.4" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="AUC of telmisartan decrease" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.e.0"><relations><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.e.4"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60" text="Ramipril and Ramiprilat : Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state Cmax and AUC of ramipril 2.3- and 2.1-fold, respectively, and Cmax and AUC of ramiprilat 2.4- and 1.5-fold, respectively. "><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.11"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.ddi.2"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.e.2"><relations><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.61.e.4"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60" text="Ramipril and Ramiprilat : Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state Cmax and AUC of ramipril 2.3- and 2.1-fold, respectively, and Cmax and AUC of ramiprilat 2.4- and 1.5-fold, respectively. "><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.60.e.11"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="5" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62" lineNumber="92" text="When co-administering telmisartan and ramipril, the response may be greater because of the possibly additive pharmacodynamic effects of the combined drugs, and also because of the increased exposure to ramipril and ramiprilat in the presence of telmisartan. " type="regular"><entity charOffset="100:132" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.0" text="additive pharmacodynamic effects" type="Specific_Interaction"/><entity charOffset="180:198" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.2" text="increased exposure" type="Increase_Interaction"/><entity charOffset="202:210" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.4" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="to ramipril" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="215:225" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.5" text="ramiprilat" type="Drug"><Normalization><mmtx cui="C0072970" phraseText="ramiprilat in the presence of telmisartan." preferredWord="ramiprilat" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="245:256" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.6" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="ramiprilat in the presence of telmisartan." preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="22:33" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.7" text="telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="38:46" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.8" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="ramipril," preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.ddi.2"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.2"><relations><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.7" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.8" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.6" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.4" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.6" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.62.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63" lineNumber="92" text="Concomitant use of MICARDIS and ramipril is not recommended." type="regular"><entity charOffset="19:27" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.0" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="Concomitant use of MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="32:40" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.1" text="ramipril" type="Drug"><Normalization><mmtx cui="C0072973" phraseText="ramipril" preferredWord="Ramipril" semType="phsu, orch"/><RxNorm RxCui="35296"/></Normalization></entity><entity charOffset="44:59" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.2" text="not recommended" type="Caution_Interaction"/><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.0" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.1" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.63.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64" text="Other Drugs : Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen. " type="negative"><entity charOffset="192:201" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.0" text="ibuprofen" type="Biomedical_Entity"><Normalization><mmtx cui="C0020740" phraseText="ibuprofen." preferredWord="Ibuprofen" semType="phsu, orch"/><RxNorm RxCui="5640"/></Normalization></entity><entity charOffset="134:143" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.1" text="glyburide" type="Biomedical_Entity"><Normalization><mmtx cui="C0017628" phraseText="glyburide," preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="107:120" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.2" text="acetaminophen" type="Biomedical_Entity"><Normalization><mmtx cui="C2917659" phraseText="with acetaminophen," preferredWord="Acetaminophen [EPC]" semType="phsu"/><RxNorm RxCui="161"/></Normalization></entity><entity charOffset="158:177" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="145:156" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.4" text="simvastatin" type="Biomedical_Entity"><Normalization><mmtx cui="C0074554" phraseText="simvastatin," preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="35:46" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.5" text="telmisartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0248719" phraseText="Co-administration of telmisartan" preferredWord="telmisartan" semType="phsu, orch"/><RxNorm RxCui="73494"/></Normalization></entity><entity charOffset="179:187" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.6" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="122:132" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.7" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.1" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.4" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.6" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.7" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.0"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.1" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.3"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.1" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.4"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.1" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.6"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.7" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.1"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.3"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.4"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.2"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.6"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.2" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.7"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.4" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.3"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.3"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.6"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.7" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.3"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.4"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.4" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.6"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.7" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.4"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.6"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.5" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.7"/><pair ddi="false" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.7" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.64.e.6"/></sentence><sentence biomedicalEntities="1" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67" lineNumber="96" text="&lt;item&gt;NSAIDS: Increased risk of renal impairment and loss of anti-hypertensive effect (7)" type="irregular"><entity charOffset="32:48" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.e.0" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="Increased risk of renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="Increased risk of renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="53:85" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.e.2" text="loss of anti-hypertensive effect" type="Specific_Interaction"/><entity charOffset="6:12" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.e.4" text="NSAIDS" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAIDS" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.66" text="Telmisartan is not expected to interact with drugs that inhibit cytochrome P450 enzymes, it is also not expected to interact with drugs metabolized by cytochrome P450 enzymes, except for possible inhibition of the metabolism of drugs metabolized by CYP2C19."><entity charOffset="0:11" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.66.e.0" text="Telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="Telmisartan" preferredWord="telmisartan" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.ddi.2"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.66" text="Telmisartan is not expected to interact with drugs that inhibit cytochrome P450 enzymes, it is also not expected to interact with drugs metabolized by cytochrome P450 enzymes, except for possible inhibition of the metabolism of drugs metabolized by CYP2C19."><entity charOffset="0:11" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.66.e.0" text="Telmisartan" type="Drug"><Normalization><mmtx cui="C0248719" phraseText="Telmisartan" preferredWord="telmisartan" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.67.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68" lineNumber="98" text="&lt;item&gt;Do not co-administer aliskiren with MICARDIS in patients with diabetes (7)" type="regular"><entity charOffset="6:26" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="42:50" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.2" text="MICARDIS" type="Drug"><Normalization><mmtx cui="C0721704" phraseText="aliskiren with MICARDIS" preferredWord="Micardis" semType="phsu, orch"/><RxNorm RxCui="218353"/></Normalization></entity><entity charOffset="27:36" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with MICARDIS" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="68:76" id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.ddi.1"><interaction trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.4" ddi="true" e1="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.3" e2="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.2" trigger="Dailymed.cfb9309f-e0df-4a55-9542-0e869fce05fb.s.68.e.0" type="Caution_Interaction"/></sentence><positiveExamples number="26"/><negativeExamples number="56"/></document>